BNKL
BIONIK LABORATORIES CORP
stock OTC

bionik laboratories (otcqx: bnkl) is a pioneering medical device and robotics company developing transformational robotic rehabilitation technologies for individuals with neurological disorders. the company is dedicated to provide individuals with restricted mobility an improvement in overall health, comfort, accessibility, and quality of life through the commercialization of its proprietary products. the company's lead program, arke™ is the most comprehensive lower-body exoskeleton that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking and other motion. currently in clinical development, arke will initially be used in a rehabilitation environment, with the goal of being made available for home use.